Literature DB >> 3262383

Leukemic cells from some adult T-cell leukemia patients proliferate in response to interleukin-4.

T Uchiyama1, M Kamio, T Kodaka, S Tamori, S Fukuhara, R Amakawa, H Uchino, K Araki.   

Abstract

The proliferative response of fresh peripheral blood leukemic cells from eight adult T cell leukemia (ATL) patients to interleukin-4 (IL-4) was studied to determine the possibility that the IL-4-mediated T-cell growth pathway is involved in the cell growth of leukemic cells in ATL. Resting lymphocytes from ten normal individuals did not proliferate in response to IL-4. Leukemic cells from two ATL patients did not respond to interleukin-2 (IL-2) or IL-4. Leukemic cells from two patients did respond to IL-2, but not to IL-4. In contrast, a strong proliferative response was observed in the IL-4 culture, but not in the IL-2 culture in the remaining four patients. Chromosome analysis of mitotic cells, performed in one of four patients, confirmed that the cells dividing in response to IL-4 were leukemic cells, but not activated normal lymphocytes. These results indicate the activation of IL-4/IL-4 receptor system in leukemic cells from some ATL patients and suggest the possible involvement of the system in the proliferation of leukemic cells and the leukemogenesis in ATL.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262383

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

2.  Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines.

Authors:  Raimundo Fernandes Araújo; Luiz Alberto Lira Soares; Cínthia Raquel da Costa Porto; Ranniere Gurgel Furtado de Aquino; Hugo Gonçalo Guedes; Pedro Ros Petrovick; Tatiane Pereira de Souza; Aurigena Antunes Araújo; Gerlane Coelho Bernardo Guerra
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

3.  Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.

Authors:  S Takemoto; J C Mulloy; A Cereseto; T S Migone; B K Patel; M Matsuoka; K Yamaguchi; K Takatsuki; S Kamihira; J D White; W J Leonard; T Waldmann; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).

Authors:  M R Zocchi; A Poggi; S Heltai; A Villa; L Inverardi; A Vicari; M G Sabbadini; M Ferrarini
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  Spontaneous production of interleukin 6 by adult T-cell leukaemia cells.

Authors:  T Sawada; H Tsuda; K Takatsuki
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  Interleukin-2 receptor beta-chain (p70-75) expressed on leukemic cells from adult T cell leukemia patients.

Authors:  T Kodaka; T Uchiyama; T Ishikawa; M Kamio; R Onishi; K Itoh; T Hori; H Uchino; M Tsudo; K Araki
Journal:  Jpn J Cancer Res       Date:  1990-09

7.  Expression of cytokine mRNA in leukemic cells from adult T cell leukemia patients.

Authors:  T Kodaka; T Uchiyama; H Umadome; H Uchino
Journal:  Jpn J Cancer Res       Date:  1989-06

Review 8.  Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.

Authors:  Nicolas Futsch; Gabriela Prates; Renaud Mahieux; Jorge Casseb; Hélène Dutartre
Journal:  Viruses       Date:  2018-12-05       Impact factor: 5.048

9.  Enhancing effect of interleukin-2 on production of parathyroid hormone-related protein by adult T-cell leukemia cells.

Authors:  N Mori; K Ohsumi; S Murakami; A Wake; F Shirakawa; I Morimoto; S Oda; S Eto
Journal:  Jpn J Cancer Res       Date:  1993-04

10.  Interleukin-2 prevents programmed cell death in adult T-cell leukemia cells.

Authors:  H Tsuda; R W Huang; K Takatsuki
Journal:  Jpn J Cancer Res       Date:  1993-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.